Bucci Tommaso, Choi Sylvia E, Tsang Christopher Tw, Yiu Kai-Hang, Buckley Benjamin Jr, Pignatelli Pasquale, Scheitz Jan F, Lip Gregory Yh, Abdul-Rahim Azmil H
Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Eur Stroke J. 2024 Nov 2:23969873241293573. doi: 10.1177/23969873241293573.
The risk of dementia in patients with stroke-heart syndrome (SHS) remains unexplored.
Retrospective analysis using the TriNetX network, including patients with ischaemic stroke from 2010 to 2020. These patients were categorised into two groups: those with SHS (heart failure, myocardial infarction, ventricular fibrillation, or Takotsubo cardiomyopathy within 30 days post-stroke) and those without SHS. The primary outcome was the 1-year risk of dementia (vascular dementia, dementia in other disease, unspecified dementia, or Alzheimer's disease). The secondary outcome was the 1-year risk of all-cause death. Cox regression analysis after 1:1 propensity score matching (PSM) was performed to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the outcomes.
We included 52,971 patients with SHS (66.6 ± 14.6 years, 42.2% females) and 854,232 patients without SHS (64.7 ± 15.4 years, 48.2% females). Following PSM, 52,970 well-balanced patients were considered in each group. Patients with SHS had a higher risk of incident dementia compared to those without SHS (HR 1.28, 95%CI 1.20-1.36). The risk was the highest during the first 31 days of follow-up (HR 1.51, 95%CI 1.31-1.74) and was mainly driven by vascular and mixed forms. The increased risk of dementia in patients with SHS, was independent of oral anticoagulant use, sex and age but it was the highest in those aged <75 years compared to ⩾75 years.
SHS is associated with increased risk of dementia. Future studies are needed to develop innovative strategies for preventing complications associated with stroke-heart syndrome and improving the long-term prognosis of these patients.
中风-心脏综合征(SHS)患者患痴呆症的风险仍未得到研究。
使用TriNetX网络进行回顾性分析,纳入2010年至2020年的缺血性中风患者。这些患者被分为两组:患有SHS的患者(中风后30天内出现心力衰竭、心肌梗死、心室颤动或应激性心肌病)和未患有SHS的患者。主要结局是痴呆症(血管性痴呆、其他疾病所致痴呆、未特定的痴呆或阿尔茨海默病)的1年风险。次要结局是全因死亡的1年风险。在进行1:1倾向评分匹配(PSM)后进行Cox回归分析,以计算结局的风险比(HRs)和95%置信区间(CIs)。
我们纳入了52971例患有SHS的患者(66.6±14.6岁,42.2%为女性)和854232例未患有SHS的患者(64.7±15.4岁,48.2%为女性)。PSM后,每组考虑52970例均衡良好的患者。与未患有SHS的患者相比,患有SHS的患者发生痴呆症的风险更高(HR 1.28,95%CI 1.20-1.36)。风险在随访的前31天最高(HR 1.51,95%CI 1.31-1.74),主要由血管性和混合性形式驱动。SHS患者痴呆症风险的增加与口服抗凝剂的使用、性别和年龄无关,但与年龄≥75岁的患者相比,年龄<75岁的患者风险最高。
SHS与痴呆症风险增加相关。未来需要开展研究以制定创新策略,预防与中风-心脏综合征相关的并发症并改善这些患者的长期预后。